돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1964809생성일: 2026년 10월 24일

4-Methylmorpholine → N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide

https://huagongshe.com/ko/reaction/1964809

반응식

참여 물질

역할이름HCID투입량
반응물4-MethylmorpholineHCID 7972—
반응물Isobutyl chloroformateHCID 62365—
반응물(S)-1-Phenyl-3-propanolamineHCID 2734520—
반응물3-(Biphenyl-4-ylsulfonyl)-1,3-thiazolidine-2-carboxylic acidHCID 57423221—
용매TetrahydrofuranHCID 8028—
생성물N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamideHCID 68623385—

반응 조건

온도-25 °C

반응 단계

N-methyl morpholine (NMM) (3.24 g, 2.5 eq, 32.15 mmol) was added to a solution of a compound of general formula (VIII) (Intermediate 8, 4.50 g, 1 eq, 12.86 mmol), e.g., 3-([1,1′-biphenyl]-4-ylsulfonyl)-1,3-thiazolidine-2-carboxylic acid, in dry THF (100 ml) and the reaction mixture was cooled down to −25° C. To the reaction mixture was then added drop wise, over a period of 5 minutes, isobutyl chloroformate (1.84 g, 1.05 eq, 13.50 mmol) in solution in dry THF (20 ml). The resulting mixture was stirred at −25° C. for 30 minutes, after which time an amine of general formula (IV) or (IV*) (commercial or Intermediate 2, 2.14 g, 1.1 eq, 14.15 mmol), e.g., (3S)-3-amino-3-phenyl-1-propanol, was added in dry THF (20 ml) over a period of 5 minutes. The mixture was allowed to gradually warm to room temperature and stirred overnight at room temperature. The solvent was removed and the residue re-dissolved in ethyl acetate (200 ml). The organic layer was washed subsequently with a saturated solution of ammonium chloride (100 ml), saturated bicarbonate (100 ml) and brine (100 ml). The combined organic phases were dried with magnesium sulfate and concentrated in vacuo, yielding the crude product of general formula ([), e.g., 3-(1,1′-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as a white solid (6.21 g, 96%). Silica gel chromatography, eluting in isocratic conditions (50% ethyl acetate in hexanes), which gave the separation of the desired two pure diastereoisomers of general formula (I), e.g., (2S)-3-([1,1′-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide (more polar compound, 3.1 g), and (2R)-3-([1,1′-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide (less polar compound, 3.0 g).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08415480B2
출처 데이터셋uspto-grants-2013_04
ORD IDord-0317478c76a2481cad0c1896af3637c6
출처 메모uspto-grants-2013_04